Alectinib in ALINA Trial: Phase III Adjuvant Therapy Study for Stage IB to IIIA ALK+ Non-Small Cell Lung Cancer Josina Reddy, MD ESMO [2023] Non-Small Cell Lung Cancer 2 Mins Read7 By. Josina Reddy, MDDate. 11/24/2023Today, the focus is on the ALINA trial, a phase three study comparing Alectinib versus chemotherapy…
